# $DNA Catalyst Posts & Social Intelligence Recap — June 03, 2026 > **Asset:** $DNA > **Date:** 2026-06-03 (June 03, 2026) > **Canonical URL:** https://cryptitalk.com/tokens/dna/2026-06-03 > **Token Profile:** https://cryptitalk.com/tokens/dna.md > **Market Rankings:** https://cryptitalk.com/rankings.md --- ## Curated Viral Posts & Community Evidence ### Post #1 by @CoinMarketCap:Coinpaper > **Author:** ([@CoinMarketCap:Coinpaper](https://x.com/CoinMarketCap:Coinpaper)) > **Metrics:** 0 likes · 0 retweets · 0 comments · 1.1K views > **Posted:** 2026-06-03T21:25:53.202278+00:00 > **Source Link:** [https://coinmarketcap.com/community/articles/6a209badcddbbd192736eca3/](https://coinmarketcap.com/community/articles/6a209badcddbbd192736eca3/) > > "DNA Protocol Breaks the Chains: Zero-Knowledge Identity Arrives on XRP Ledger DNA Protocol and XRP Ledger: The Rise of Sovereign Identity Powered by Zero-Knowledge Proofs DNA Protocol, a platform built around decentralized identity, is advancing a model of sovereign id" ### Post #2 by @CoinMarketCap:blockonomi > **Author:** ([@CoinMarketCap:blockonomi](https://x.com/CoinMarketCap:blockonomi)) > **Metrics:** 0 likes · 0 retweets · 0 comments · 700 views > **Posted:** 2026-06-03T14:06:08.389291+00:00 > **Source Link:** [https://coinmarketcap.com/community/articles/6a20348e757b1f4341c7bee3/](https://coinmarketcap.com/community/articles/6a20348e757b1f4341c7bee3/) > > "Eli Lilly (LLY) Secures $1.9 Billion Partnership With Ascidian for Kidney Disease Therapies Key Highlights Pharmaceutical leader Eli Lilly has entered into a strategic partnership with Ascidian Therapeutics valued at up to $1.9 billion The collaboration focuses on creating innovativ" ### Post #3 by @CoinMarketCap:blockonomi > **Author:** ([@CoinMarketCap:blockonomi](https://x.com/CoinMarketCap:blockonomi)) > **Metrics:** 0 likes · 0 retweets · 0 comments · 100 views > **Posted:** 2026-06-03T06:15:41.991535+00:00 > **Source Link:** [https://coinmarketcap.com/community/articles/6a1fc66554b41c4974ff8af2/](https://coinmarketcap.com/community/articles/6a1fc66554b41c4974ff8af2/) > > "NewLimit Series C: Armstrong-Backed Longevity Startup Raises $435M TLDR: NewLimit Series C raised $435M led by Founders Fund for longevity biotech expansion and clinical readiness. Startup targets epigenetic reprogramming therapies aimed at restoring youthfu" ### Post #4 by @CoinMarketCap:cryptonews > **Author:** ([@CoinMarketCap:cryptonews](https://x.com/CoinMarketCap:cryptonews)) > **Metrics:** 0 likes · 0 retweets · 0 comments > **Posted:** 2026-06-03T08:45:44.312056+00:00 > **Source Link:** [https://coinmarketcap.com/community/articles/6a1fe98d2659cb3a656f4116/](https://coinmarketcap.com/community/articles/6a1fe98d2659cb3a656f4116/) > > "Brian Armstrong’s NewLimit Raises $435M for Human Trials NewLimit, a longevity biotech startup co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in Series C funding to move its first age-reprogramming medicine toward human trials." --- *Generated by Context Pilot Social Intelligence Engine.*